DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
F•••• B••••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Sep 30, 2023sponsor not established · possible relationship
Also written as: Undrawn Commitment
Nothing material in the last 200 days. Last change: 30 Sep 2023, $26.7M principal held by 1 lender; matures Dec 2026.
Mark path, consensus per quarter end
101¢ · 99¢ · 100¢Q4 2022 to Q3 2023
Principal held
at least $26.7M
sum of BDC pieces, a lower bound
Fair value
$39.8M
100c on cost, debt pieces
Unfunded
$6.7M
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Dec 3, 2026
no dated debt inside 24 months
On the tape since
Mar 31, 2022
latest Sep 30, 2023
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2023, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | $26.7M | 100¢ | +1 pts |
Every BDC piece · 5 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | term loan first lien F•••• L••• S•••••• D••• S•••+711, 0.50% F•••• M••••••• D••• 12/03/26 | $20.0M | $19.9M 100c | S+711 bp |
| M••••• F•••••••• I••••••••• C••• | term loan first lien F•••• L••• S•••••• D••• S•••+686, 0.50% F•••• M••••••• D••• 12/03/26 | $6.7M | -$27,000 129c | S+686 bp |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | Not disclosed | |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | $19.9M 100c | |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | Not disclosed |
Capital structure as the BDCs see it
latest quarter end Sep 30, 2023
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Sep 30, 2023 | at least $26.7M | 100c | S+711 bp | Dec 3, 2026 | 1 |
Equity pieces beside the debt: other ($19.9M fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2023 | 1 | $26.7M | $19.9M | 100c | 0 |
| Jun 30, 2023 | 1 | $26.7M | $19.8M | 99c | 0 |
| Mar 31, 2023 | 1 | $26.7M | $13.2M | n/a | 0 |
| Dec 31, 2022 | 1 | $26.7M | $13.3M | 101c | 0 |
All 5 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2022 | 1 | $0 | $0 | n/a | 0 |
What changed
- Facility left every BDC scheduleSep 30, 2023
- New borrower on a BDC scheduleMar 31, 2022
Sponsor
Possible relationship, not established: A•••••• C•••••• M••••••••• L•, because a company of this name is on the sponsor's portfolio page (confidence 0.65). No deal announcement or filing names it as a party, so it is not shown as this borrower’s sponsor.
- A•••••• C•••••• M••••••••• L•
- the sponsor's own portfolio page lists a company of this nameestimatedaislingcapital.com"••• Locked"
Identity
- Group key
- F•••• B••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it